The global dry eye disease market is estimated to grow at a CAGR of 4.6% during the forecast period. The major factors contributing to the growth of the market include the increasing prevalence of diabetes associated ocular problems, emerging demand for contact lenses and awareness programs for dry eye disease. People suffering from diabetes are prone to diabetic eye conditions including diabetic retinopathy, diabetic macular edema (DME), cataract, glaucoma and other diseases. One of the major causes of these diseases is the change in retinal blood vessels that causes leakage of fluid resulting in vision loss which as a result affect tear film of the eyes to some extent.
To Request a Free Sample of our Dry Eye Disease Market: https://www.omrglobal.com/request-sample/dry-eye-disease-market
According to the European Society of Retina Specialists (EURETINA), about 25% of diabetic patients are suffering from Diabetic Eye Disease (DED) in European countries. Italy is the highest affected country with 34% followed by the UK (29%). EURETINA has also estimated that in the EU region, there are about 4 million individuals over the age of 40 years suffering from any kind of dry eye disease. Each year, 4.6% of Europeans with diabetes are newly affected by any DED, corresponding to more 770,000 individuals in the EU per year. Hence, a significant prevalence of diabetic eye conditions is one of the major factors for the growing incidences of dry eye disease.
(Get 15% Discount on Buying this Report)
A full Report of Dry Eye Disease Market is Available at: https://www.omrglobal.com/industry-reports/dry-eye-disease-market
Global Dry Eye Disease Market Segmentation
By Type
· Aqueous
· Evaporative
· Global Dry Eye Disease Market by Treatment
· Anti-Inflammatory Drugs
· Lifitegrast
· Corticosteroid
· Cyclosporine
· Artificial Tears
· Punctal Plug
· Secretagogue
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
